S Gastrointestinal And Liver Disease 12th Edition Hot

: New curative treatment paradigms for Hepatitis B virus (HBV) suppression and modern direct-acting antiviral protocols for Hepatitis C.

Beyond the “hot topics,” the 12th edition is packed with improvements that enhance its utility for busy clinicians: s gastrointestinal and liver disease 12th edition hot

One of the most immediate changes in hepatology practice is the official nomenclature shift highlighted in this edition. The text fully replaces Nonalcoholic Fatty Liver Disease (NAFLD) with . This shift reflects a more accurate, non-stigmatizing, biomarker-driven framework. The chapter outlines the specific diagnostic criteria requiring at least one of five cardiometabolic risk factors alongside hepatic steatosis. It also delivers the latest trial data on emerging therapeutic options, such as THR-beta agonists and GLP-1 receptor co-agonists. 2. AI-Powered Endoscopy and Digital Intelligence : New curative treatment paradigms for Hepatitis B

The 12th edition emphasizes the for non-alcoholic fatty liver disease (NAFLD) and IBS. When eating out: This shift reflects a more accurate

Available via VitalSource eTextbook and Expert Consult eBook.

. From novel biologics to small molecules, the updated text serves as a roadmap for managing refractory cases. Similarly, you’ll find the latest protocols for Chronic Hepatitis B and C

Sleisenger and Fordtran's Gastrointestinal and Liver Disease (12th Edition)